Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies

NCT05448222 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT05448222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05448222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
December 1, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, sarcopenia